March 24, 2022

Pharma
March 24, 2022
Evidence Grows That Vaccines Lower the Risk of Getting Long COVID
March 24, 2022
Sinovac Boosters Provide Key Protection for Older People, New Study Finds
March 24, 2022
Experts Call U.S. Drug Shortages ‘National Security Issue’ That Predates the Pandemic
March 24, 2022
High from Hemp: States Wrestle with Chemically Made THC
March 24, 2022
Rich Countries Getting New COVID Vaccine Before Poorer Ones
March 24, 2022
Pressured By Patients, FDA Reviews ALS Drug with Modest Data
March 24, 2022
EU Regulator Advises AstraZeneca’s COVID Drug Be Cleared
March 23, 2022
Moderna Says Its Low-Dose COVID Shots Work for Kids Under 6
March 22, 2022
9 Million Children to Be Vaccinated Against Polio in Africa
March 22, 2022
FDA to Consider Future of COVID Booster Doses
March 22, 2022
Vaccines Protect Against Infection from Omicron Subvariant–But Not for Long
March 21, 2022
The Covid-19 Vaccine Market Is Getting Crowded–As Demand Begins to Wane
March 21, 2022
Doctors Finding Hurdles to Using Pills to Treat COVID-19
March 21, 2022
AI Suggested 40,000 New Possible Chemical Weapons in Just Six Hours
March 21, 2022
Controversial Alzheimer’s Drug Approval Ignites FDA Reform Debate
March 18, 2022
Big Pharma Faces an Ethical Dilemma: Should They Keep Selling to Russia?
March 18, 2022
Ivermectin Didn’t Reduce Covid-19 Hospitalizations in Largest Trial to Date
March 18, 2022
Moderna Seeks FDA Authorization for 4th Dose of COVID Shot
March 18, 2022
Malawi, Neighbors to Begin Mass Vaccination Campaigns Against Polio
March 17, 2022
Covid’s ‘Silver Lining’: Research Breakthroughs for Chronic Disease, Cancer, and the Common Flu
March 17, 2022
More Than 30 Companies to Start Making Pfizer’s COVID Pill
March 17, 2022
What Happened to Hong Kong?
March 17, 2022
The COVID Booster Debate Is Back
March 16, 2022